Shicheng (Steven) Yang
Durham, North Carolina, United States
2K followers
500+ connections
2K followers
500+ connections
About
Develop novel CAT T and TCR T for cancer management.
Activity
-
From cowboy dreams to revolutionizing cancer treatment. 🤠➡️🧬 In the debut episode of The ImmunoVerse podcast, I sit down with legendary…
From cowboy dreams to revolutionizing cancer treatment. 🤠➡️🧬 In the debut episode of The ImmunoVerse podcast, I sit down with legendary…
Liked by Shicheng (Steven) Yang
-
In a new study by Carl June and his Team at UPenn, CAR-T cells were engineered to secrete IL-18, yielding remarkable clinical results that offer real…
In a new study by Carl June and his Team at UPenn, CAR-T cells were engineered to secrete IL-18, yielding remarkable clinical results that offer real…
Liked by Shicheng (Steven) Yang
-
A next-generation “armored” CAR T cell therapy shows promising results in a small study of patients whose B-cell lymphomas continued to resist…
A next-generation “armored” CAR T cell therapy shows promising results in a small study of patients whose B-cell lymphomas continued to resist…
Liked by Shicheng (Steven) Yang
Experience
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Education
-
-
-
-
-
More activity by Shicheng (Steven)
-
Immatics US has officially opened its new 100,000-square-foot cell-therapy manufacturing plant in Stafford, further scaling its operations in the…
Immatics US has officially opened its new 100,000-square-foot cell-therapy manufacturing plant in Stafford, further scaling its operations in the…
Liked by Shicheng (Steven) Yang
-
𝐂𝐚𝐧𝐜𝐞𝐫 𝐆𝐞𝐧𝐞𝐬/𝐌𝐚𝐫𝐤𝐞𝐫𝐬 𝐁𝐫𝐞𝐚𝐤𝐝𝐨𝐰𝐧 🔬 ➡️ In this visual presentation, note how the sizes of gene names vary, reflecting…
𝐂𝐚𝐧𝐜𝐞𝐫 𝐆𝐞𝐧𝐞𝐬/𝐌𝐚𝐫𝐤𝐞𝐫𝐬 𝐁𝐫𝐞𝐚𝐤𝐝𝐨𝐰𝐧 🔬 ➡️ In this visual presentation, note how the sizes of gene names vary, reflecting…
Liked by Shicheng (Steven) Yang
-
https://lnkd.in/ec8HJ2wm Thrilled to see the CRISPR‑edited adoptive T cell therapy we pioneered at the NIH changing lives in the clinic. More than…
https://lnkd.in/ec8HJ2wm Thrilled to see the CRISPR‑edited adoptive T cell therapy we pioneered at the NIH changing lives in the clinic. More than…
Liked by Shicheng (Steven) Yang
-
Time change: 10:30am-11:45! Hope to see you there! Poster board #2055.
Time change: 10:30am-11:45! Hope to see you there! Poster board #2055.
Liked by Shicheng (Steven) Yang
-
Yesterday, I was honored to deliver the opening ED presentation at the American Association for Cancer Research Annual Meeting where I shared…
Yesterday, I was honored to deliver the opening ED presentation at the American Association for Cancer Research Annual Meeting where I shared…
Liked by Shicheng (Steven) Yang
-
In case you missed it, a clinical trial led by Steven A. Rosenberg, M.D., Ph.D., Chief of our Surgery Branch, showed that a new form of tumor…
In case you missed it, a clinical trial led by Steven A. Rosenberg, M.D., Ph.D., Chief of our Surgery Branch, showed that a new form of tumor…
Liked by Shicheng (Steven) Yang
-
Loved hearing my former thesis advisor, Marco Ruella, speak at Cellicon Valley today about my favorite protein CD5. He highlighted the preclinical…
Loved hearing my former thesis advisor, Marco Ruella, speak at Cellicon Valley today about my favorite protein CD5. He highlighted the preclinical…
Liked by Shicheng (Steven) Yang
-
Today we announced the publication of the 18-month data from our Phase 1 clinical trial for bemdaneprocel, an investigational cell therapy for…
Today we announced the publication of the 18-month data from our Phase 1 clinical trial for bemdaneprocel, an investigational cell therapy for…
Liked by Shicheng (Steven) Yang
-
It’s podcast launch day! The ImmunoVerse™️ is now streaming on all your favorite platforms! 🚀 I’m honored to kick off this new Moffitt Cancer…
It’s podcast launch day! The ImmunoVerse™️ is now streaming on all your favorite platforms! 🚀 I’m honored to kick off this new Moffitt Cancer…
Liked by Shicheng (Steven) Yang
-
Fully recognizing I stand on the shoulders of giants, it was a very happy task indeed to be asked to reflect on the many contributions of the Surgery…
Fully recognizing I stand on the shoulders of giants, it was a very happy task indeed to be asked to reflect on the many contributions of the Surgery…
Liked by Shicheng (Steven) Yang
-
𝐈𝐧 𝐕𝐢𝐯𝐨 𝐂𝐀𝐑 𝐓: The Future of Cell Therapy is Now 👇 Capstan Therapeutics today has officially launched Phase 1 trials for CPTX2309, a…
𝐈𝐧 𝐕𝐢𝐯𝐨 𝐂𝐀𝐑 𝐓: The Future of Cell Therapy is Now 👇 Capstan Therapeutics today has officially launched Phase 1 trials for CPTX2309, a…
Liked by Shicheng (Steven) Yang
Other similar profiles
Explore collaborative articles
We’re unlocking community knowledge in a new way. Experts add insights directly into each article, started with the help of AI.
Explore More